Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...

An estimated 6.9 million Americans age 65 and older are living with Alzheimer's dementia today, according to the National ...

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

The findings suggest that symptoms of Alzheimer's are closely linked to the makeup of the gut. Today, evidence strongly ...

Join the Walk to End Alzheimer's on October 5, 2024 at the National WWI Museum and Memorial. Learn more about this and other ...

Across the country, the Alzheimer's Association reports nearly 7 million people are fighting the disease. 1 in 3 seniors dies ...

This past weekend was the annual Walk to End Alzheimer’s in Eagle. Every year, the event is gaining in attendance. We all are ...

Explaining the Alzheimer’s Journey will be held on October 10 at the University of Findlay. The event will focus on the ...

Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...